Pfizer Discontinues Phase 3 Trial of Sutent® in Metastatic Colorectal Cancer
- Details
- Category: Pfizer

AstraZeneca Development Partner, Pozen, Inc., Submits New Drug Application for PN400
- Details
- Category: AstraZeneca

Bayer Schering Pharma Extends Research Portfolio in the Field of Cancer-Related Targets
- Details
- Category: Bayer

Novo Nordisk reaches settlement with the Danish authorities regarding Oil-for-Food activities
- Details
- Category: Novo Nordisk

Lundbeck receives FDA Complete Response Letter on Serdolect® for the treatment of schizophrenia
- Details
- Category: Lundbeck

Sutent Significantly Improved Progression-Free Survival
- Details
- Category: Pfizer

GSK and Chroma Therapeutics form alliance to develop novel macrophage-targeted drugs
- Details
- Category: GlaxoSmithKline

More Pharma News ...
- New biological therapy Ilaris® approved in US
- Nycomed receives Marketing Authorization for Pantoprazole 20mg OTC from European Commission
- GSK announces a strategic alliance with Dr. Reddy's Laboratories Ltd
- Abbott Initiates Trial of Next-Generation XIENCE PRIME(TM) Drug Eluting Stent
- Boehringer Ingelheim and Vitae Pharmaceuticals announce a major collaboration
- Eli Lilly and Company Announces New Drug Discovery Initiative
- Novartis demonstrates capabilities of cell-based technology for production of A(H1N1) vaccine